Squarepoint’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-12,186
| Closed | -$107K | – | 4470 |
|
|
2025
Q4 | $107K | Sell |
12,186
-4,184
| -26% | -$40.9K | ﹤0.01% | 4031 |
|
|
2025
Q3 | $201K | Buy |
+16,370
| New | +$154K | ﹤0.01% | 3939 |
|
|
2025
Q1 | – | Sell |
-15,470
| Closed | -$205K | – | 4841 |
|
|
2024
Q4 | $205K | Buy |
+15,470
| New | +$144K | ﹤0.01% | 4455 |
|
|
2024
Q3 | – | Sell |
-6,517
| Closed | -$145K | – | 4280 |
|
|
2024
Q2 | $145K | Buy |
+6,517
| New | +$201K | ﹤0.01% | 3730 |
|
|
2023
Q4 | – | Sell |
-20,776
| Closed | -$448K | – | 4145 |
|
|
2023
Q3 | $448K | Buy |
20,776
+14,930
| +255% | +$586K | ﹤0.01% | 2873 |
|
|
2023
Q2 | $395K | Buy |
5,846
+4,151
| +245% | +$1.72M | ﹤0.01% | 2789 |
|
|
2023
Q1 | $791K | Buy |
+1,695
| New | +$897K | ﹤0.01% | 2039 |
|
|
2022
Q4 | – | Sell |
-2,731
| Closed | -$888K | – | 3302 |
|
|
2022
Q3 | $888K | Buy |
2,731
+1,842
| +207% | +$593K | ﹤0.01% | 1846 |
|
|
2022
Q2 | $235K | Buy |
+889
| New | +$227K | ﹤0.01% | 2386 |
|
|
2022
Q1 | – | Sell |
-706
| Closed | -$249K | – | 3063 |
|
|
2021
Q4 | $249K | Sell |
706
-2,263
| -76% | -$705K | ﹤0.01% | 2561 |
|
|
2021
Q3 | $759K | Buy |
2,969
+2,183
| +278% | +$774K | ﹤0.01% | 1727 |
|
|
2021
Q2 | $524K | Sell |
786
-704
| -47% | -$406K | ﹤0.01% | 2091 |
|
|
2021
Q1 | $1.29M | Buy |
1,490
+953
| +177% | +$1.01M | 0.01% | 1327 |
|
|
2020
Q4 | $498K | Sell |
537
-462
| -46% | -$486K | ﹤0.01% | 1817 |
|
|
2020
Q3 | $1.03M | Buy |
999
+720
| +258% | +$775K | 0.01% | 987 |
|
|
2020
Q2 | $283K | Buy |
+279
| New | +$259K | ﹤0.01% | 1633 |
|
|
2020
Q1 | – | Sell |
-2,275
| Closed | -$2.44M | – | 2071 |
|
|
2019
Q4 | $2.44M | Buy |
+2,275
| New | +$2.32M | 0.01% | 788 |
|
|
2019
Q1 | – | Sell |
-2,067
| Closed | -$2.39M | – | 2238 |
|
|
2018
Q4 | $2.39M | Buy |
+2,067
| New | +$2.32M | 0.03% | 615 |
|
|
2017
Q4 | – | Sell |
-282
| Closed | -$379K | – | 2164 |
|
|
2017
Q3 | $379K | Buy |
+282
| New | +$297K | 0.01% | 1075 |
|
|
2017
Q1 | – | Sell |
-863
| Closed | -$462K | – | 1642 |
|
|
2016
Q4 | $462K | Buy |
+863
| New | +$431K | 0.02% | 881 |
|
|
2016
Q1 | – | Sell |
-1,484
| Closed | -$1.13M | – | 1250 |
|
|
2015
Q4 | $1.13M | Buy |
+1,484
| New | +$985K | 0.12% | 235 |
|
Other funds holding KYNB
AC
Squarepoint's KYNB Position: Q1 2026 in Review
Squarepoint sold out of Kyntra Bio (KYNB) in Q1 2026, closing a stake of 12,186 shares — an estimated $107K sold.
Squarepoint first reported a position in KYNB in Q4 2015 and held it in 21 quarters. The position peaked at $2.44M in Q4 2019. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.
- Squarepoint reported no remaining Kyntra Bio position as of Q1 2026 after selling out during the quarter.
- Squarepoint sold 12,186 Kyntra Bio shares in Q1 2026, an estimated $107K.
- Squarepoint first reported a position in Kyntra Bio in Q4 2015 and held it in 21 quarters.
- Squarepoint's Kyntra Bio position peaked at $2.44M in Q4 2019.
- 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.